Biomax Pharmaceutical Co Ltd
- A03 - Agentes contra padecimientos funcionales del estómago e intestino
- DOTACID tablet 40 mg
- DOTACID tablet 80 mg
- A10 - Antidiabéticos
- GLISU OD tablet 1 mg
- GLISU OD tablet 2 mg
- GLISU OD tablet 3 mg
- GLISU OD tablet 4 mg
- B02 - Antihemorrágicos
- ZAXID tablet 250 mg+250 mg
- B03 - Preparados antianémicos
- CARBOSYL syrup
- CARBOSYL tablet
- H02 - Corticosteroides para uso sistémico
- DEPOMAX powder and solvent for solution for injection 1 g
- DEPOMAX suspension for injection 40 mg/1 ml
- J01 - Antibacterianos para uso sistémico
- CLAVOGARD powder for solution for injection 1 g+200 mg
- CLAVOGARD powder for syrup 200 mg/5 ml+28.5 mg/5 ml
- CLAVOGARD tablet 200 mg+28.5 mg
- CLAVOGARD tablet 250 mg+125 mg
- CLAVOGARD tablet 500 mg+125 mg
- FUROMAX powder for solution for injection 750 mg
- FUROMAX tablet 500 mg
- KAMPI powder for solution for injection 1 g
- KAMPI powder for solution for injection 250 mg
- NAPI D tablet 250 mg+250 mg
- OBACT tablet 200 mg
- OBACT tablet 400 mg
- OFLAGARD O tablet 200 mg+400 mg
- OFLAGARD tablet 200 mg
- OFLAGARD tablet 400 mg
- M01 - Antiinflamatorios y antirreumáticos
- DICIMAX capsule, hard 50 mg
- DICIMAX G tablet 50 mg+750 mg
- FLAMACE P tablet 100 mg+500 mg
- FLAMACE prolonged-release tablet 200 mg
- FLAMACE S tablet 100 mg+15 mg
- FLAMACE SP tablet 100 mg+500 mg+15 mg
- FLAMACE tablet 100 mg
- M03 - Relajantes musculares
- FLAMACE MR prolonged-release tablet 250 mg+100 mg+500 mg
- N02 - Analgésicos
- DOLMAX tablet 100 mg
- FS D tablet 37.5 mg+325 mg+10 mg
- FS PLUS tablet 37.5 mg+325 mg
- FS solution for injection 100 mg/2 ml
- R06 - Antihistamínicos para uso sistémico
- CHOCY oral drops, solution 1.5 mg/ml+55 mg/ml
- CHOCY syrup 2 mg/5 ml+275 mg/5 ml